Senior Pricing & Market Access judgement, powered by AI agents
Market access no longer waits. Joint clinical assessment, tighter launch windows and reference pricing across borders mean questions arrive earlier, carry more weight, and demand answers sooner. Cellbyte was created for exactly this environment.
We approach it from both sides of the problem: the commercial judgement that market access decisions demand, and the technology that makes those decisions possible at the pace now required. Our engagements bring the two together under senior leadership, with one measure of success: the decisions our clients are able to make.
Discover our AI-powered services
“
Cellbyte consolidates complex HTA data in a structured way, enabling users to find insights in just a few clicks. Its AI analyzes multiple analogs simultaneously, examining study designs, outcomes, and rationales, which can now be completed in few minutes instead of hours. The platform also ensures reliability by linking each insight directly to its original source.
Gustavo Agreda Duffaut
Global Market Access Manager, Oncology Pipeline, Bayer AG